形状的变化:内皮细胞转移为癌症进展的驱动因素
Lucia Giordanengo1, Alessia Proment1,2, Virginia Botta1
1Department of Oncology, Translational Oncology Laboratory "Paola Gilardi", San Luigi Gonzaga University Hospital, University of Turin, 10043 Orbassano, Italy.
International journal of molecular sciences
|July 12, 2025
概括
内皮转移到介质酶转移 (EndMT) 通过改变瘤微环境来驱动瘤生长. 了解EndMT机制为癌症进展和治疗抵抗提供了新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 瘤微环境是一个微环境.
背景情况:
- 内皮细胞到介质细胞的转变 (EndMT) 涉及从内皮细胞到介质细胞表型的细胞切换.
- 在癌症的发展和进展中,EndMT的重要作用越来越被认可.
研究的目的:
- 审查EndMT在瘤进展中的关键作用.
- 要突出推动EndMT在癌症中的分子机制.
- 讨论EndMT在瘤发育的所有阶段的参与.
主要方法:
- 关于EndMT在癌症进展中的文献综述.
- 对参与EndMT的分子通路的分析.
- 综合EndMT对瘤微环境,免疫力和治疗耐药性的影响.
主要成果:
- EndMT促进瘤细胞的增殖和存活.
- 终结MT有助于形成与癌症相关的纤维细胞.
- 终端MT与免疫逃避,转移和治疗耐药性有关.
结论:
- EndMT是瘤生长和进展的关键因素.
- 针对EndMT途径提供了新的治疗机会.
- 对EndMT机制的进一步研究可以改善癌症治疗策略.
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


